U.S. Stock News

Herbalife (HLF) has quietly turned into a comeback story, with the stock climbing sharply over the past month and past 3 months, even as long term returns still lag badly. See our latest analysis for Herbalife. At around $14.30 per share, Herbalife’s powerful recent share price momentum, including a triple digit year to date share price return, contrasts sharply with its weak five year total shareholder return. This suggests sentiment has only recently turned. If this rebound has you...

Wondering if Box is quietly becoming a value play while everyone chases flashier tech names? You are not alone, and this article is designed to unpack whether the current price really makes sense. Despite a solid 56.2% gain over five years, Box is down 0.7% over the last week, 1.9% over the last month, and 3.7% year to date, leaving it 5.7% lower than a year ago. Recent attention has focused on Box's ongoing push into AI powered content management and deeper integrations with major cloud...

Lucid Group (LCID) has been grinding through a rough stretch in the market, and that slide is forcing investors to revisit the core EV thesis. Let us break down what the latest performance actually signals. See our latest analysis for Lucid Group. Over the past year, Lucid’s shrinking 1 year total shareholder return and steep year to date share price decline suggest momentum is clearly fading as investors reassess execution risk and the pace of future growth. If Lucid’s recent volatility has...

Strive Asset Management (ASST) has been sliding, with shares now under 1 dollar after months of selling pressure. That slump invites a closer look at what the underlying business performance really suggests. See our latest analysis for Strive Asset Management. Over the past year, the share price return has been sharply negative, with a 90 day share price return of minus 78.51 percent and year to date share price return of minus 86.8 percent, signaling that momentum is clearly fading despite...

Baird recently upgraded Tandem Diabetes Care to Outperform after the company reported third-quarter 2025 revenues above forecasts, maintained its full-year US$1.00 billion guidance, and advanced its product ecosystem with FDA clearance for the Android version of its Tandem Mobi app and plans for a mid-2026 Mobi-T insulin pump launch. These developments highlight how Tandem is leaning on product innovation and expanding digital accessibility to support its insulin pump platform and recurring...

Suburban Propane Partners, L.P. recently priced and completed a private offering of US$350,000,000 6.500% senior unsecured notes due December 15, 2035, with interest payable semi-annually under Rule 144A and Regulation S. The partnership plans to use the proceeds, alongside its revolving credit facility, to redeem its existing 5.875% senior notes due 2027, reshaping both the maturity profile and cost of its debt capital. We’ll now examine how refinancing the 2027 notes with new 2035 debt...

If you are wondering whether Levi Strauss is still fairly priced after its recent performance, or if there is real value hiding in plain sight, this breakdown can help you consider whether the current share price aligns with the fundamentals. Levi Strauss has quietly delivered solid gains, with the stock up 0.6% over the last week, 6.4% over the past month, 25.0% year to date, and 33.5% over the last year. This pattern may suggest that the market is steadily warming to its story. Recent...

Paramount Group (PGRE) has quietly delivered a strong run for investors over the past year, even as office real estate remains out of favor. With shares up about 41% year over year, it is worth a closer look. See our latest analysis for Paramount Group. The stock’s 1 year total shareholder return of 41.42% alongside a 32.86% year to date share price return suggests sentiment has meaningfully improved, even if recent weekly moves have cooled. This signals momentum that is moderating rather...

If you are wondering whether Target is a bargain or a value trap at today’s price, you are not alone. This breakdown is designed to help you decide with confidence. After a tough stretch that still has the stock down 28.1% year to date and 21.2% over the last year, the shares have recently bounced, gaining 4.2% in the last week and 11.4% over the past month. That rebound has come as investors digest a stream of updates around consumer spending resilience, shifting retail competition, and...

Fidelis Insurance Holdings recently reported that, over the past two years, net premiums earned have expanded at an annualized 17.1%, with analysts now forecasting 10.1% revenue growth over the next 12 months and further strengthening of the company’s capital position. This combination of sustained premium growth and an upbeat outlook for revenue and capital strength suggests Fidelis is consolidating its competitive position in specialty insurance and reinsurance. With Fidelis’s robust net...

Nova (NVMI) caught investors attention after fresh analyst calls, including new coverage from Morgan Stanley and an updated view from Jefferies, spotlighted its role in AI driven semiconductor manufacturing demand. See our latest analysis for Nova. Those upbeat calls landed just as the stock hit a soft patch, with the latest 7 day share price return of minus 10.08 percent and a 1 day move of minus 5.38 percent. However, that pullback sits against a powerful backdrop of a 48.44 percent year to...

Wondering if Millrose Properties is still a smart buy after its recent run, or if the easy money has already been made? This breakdown is for you. The stock is up a strong 35.6% year to date, even after a choppy recent stretch with a 0.9% gain over the last 30 days and a 7.4% pullback in just the past week. Much of that move has been driven by growing investor optimism around the company’s portfolio repositioning in higher demand rental markets and its progress on streamlining...

The Hanover Insurance Group recently reported quarterly revenue of US$1.67 billion, beating earnings expectations, and highlighted plans to redeem all US$375,000,000 of its 4.500% Notes due 2026 on January 15, 2026, alongside a board-approved quarterly dividend increase to US$0.95 per share paid on December 26, 2025, and the launch of its Hanover Specialty Industrial Property Advantage product for higher-risk small and mid-sized businesses. Together, the earnings beat, balance sheet action...

Harmonic announced that Czech Television, the Czech Republic’s public broadcaster, has adopted Harmonic’s software-based XOS Advanced Media Processor to bring transcoding in-house and upgrade its streaming workflow with AI-powered encoding, multi-profile outputs, and inclusive audio features. This collaboration highlights growing adoption of Harmonic’s cloud-native XOS platform in Europe, reinforcing the company’s positioning in premium, broadcast-grade streaming solutions. We’ll now explore...

If you have been wondering whether Kyndryl Holdings at around $26.77 is a bargain or a value trap, you are not alone. This stock has quietly become one of the more debated turnaround plays in tech services. Despite being down 24.6% year to date and 21.5% over the last year, the share price is still up 136.7% over three years, with an 11.0% rise in the last month. A small 2.5% pullback over the last week hints at some renewed volatility. That price action has played out alongside ongoing...

If you are wondering whether Applied Materials is still worth considering after a strong run, or if you are late to the party, you are in the right place to unpack what the current price is really telling us. Despite some recent volatility, with the stock down 9.8% over the last week, it is still up 8.6% over 30 days and 51.5% year to date, compounding to 51.6% over 1 year, 140.8% over 3 years and 208.5% over 5 years. Those swings are happening against a backdrop of ongoing AI and chip...

Opera (NasdaqGS:OPRA) just flipped the switch on public access to Opera Neon, its subscription based AI browser, while also affirming a semi annual dividend. This combination directly spotlights both innovation and balance sheet confidence. See our latest analysis for Opera. These announcements land after a choppy stretch, with the share price at $14.0 and a 90 day share price return of minus 28.64 percent, even though the three year total shareholder return of 189.66 percent still signals...

If you are wondering whether Karman Holdings is still a smart buy after its big run up, or if most of the upside is already priced in, you are not alone. The stock has pulled back about 3.5% over the last week, but it is still up 11.4% in the past month and an eye catching 116.1% year to date. That indicates the market has rapidly rewritten its expectations. Much of this momentum has been driven by growing investor attention on Karman's role in the broader capital goods space, with traders...

Recent trading context and performance snapshot Boston Scientific (BSX) has been quietly grinding higher, with the stock gaining about 2 % over the past week even after a roughly 7 % pullback over the past month. See our latest analysis for Boston Scientific. Zooming out, that recent 1 week share price gain sits against a modest year to date share price return in the mid single digits, while a strong multi year total shareholder return suggests the longer term momentum story is still very...

Worthington Enterprises (WOR) has just posted Q2 2026 results with revenue of about $327 million and EPS of $0.56, setting the stage against a year in which trailing 12 month revenue reached roughly $1.25 billion and EPS came in at $2.15. The company has seen quarterly revenue move from about $274 million in Q2 2025 to $327 million in Q2 2026, while EPS has shifted from $0.57 to $0.56 over the same period, as wider trailing margins now frame how investors will parse this latest print...

Wondering if Chewy is finally priced like a long term winner or still stuck in the bargain bin of e commerce stocks? This breakdown will walk you through what the current share price is really implying. Chewy’s stock has been choppy, sitting around $32.79 after a 7.3% drop over the last week and a 5.4% slide over the past month, but it is still up 2.9% over the last year despite a rough 3 year and 5 year stretch. Recent moves have been driven by shifting sentiment around pet spending, with...

Humana has announced that longtime Insurance Segment President George Renaudin will retire by the third quarter of 2026, with former Amazon healthcare leader Aaron Martin joining in January 2026 to oversee Medicare Advantage before eventually assuming Renaudin’s role. The move consolidates Humana’s Medicare Advantage operations under a single leader with deep technology and digital health experience, while maintaining continuity through Renaudin’s advisory role and internal promotion of...

Luckin Coffee (OTCPK:LKNC.Y) has quietly turned into a long term comeback story, with the stock up roughly 49% over the past year even after a choppy past 3 months. See our latest analysis for Luckin Coffee. Even with an 8.75% 1 day share price return lifting the stock back to $34.8, the 30 day and 90 day share price returns are still negative. However, the 1 year total shareholder return of 49.1% suggests the longer term momentum story remains very much intact. If Luckin’s rebound has you...

Children's Place (PLCE) just turned in a mixed Q3 2026 update, with revenue of about $339 million and a basic EPS loss of roughly $0.19 as the retailer continues to work through a difficult turnaround. The company has seen quarterly revenue move from around $320 million in Q2 2025 to $390 million in Q3 2025 and then to $339 million this quarter, while EPS has swung from a $2.51 loss in Q2 2025 to a $1.57 profit in Q3 2025 and back to losses of $0.24 in Q2 2026 and $0.19 in Q3 2026. This...